Environmental Risks and Toxicity of Fipronil and Imidacloprid Used in Pets Ectoparasiticides
Author:
De Marchi Lucia1ORCID, Oliva Matteo2, Nobile Maria3ORCID, Carere Mario4ORCID, Chiesa Luca Maria3, Degl’Innocenti Donatella5ORCID, Lacchetti Ines4ORCID, Mancini Laura4, Meucci Valentina1ORCID, Pretti Carlo12ORCID, Vasarri Marzia5ORCID, Villa Roberto Edoardo3ORCID, Intorre Luigi1ORCID
Affiliation:
1. Veterinary Teaching Hospital, Department of Veterinary Sciences, University of Pisa, 56124 Pisa, Italy 2. Consortium for the Interuniversity Center of Marine Biology and Applied Ecology “G. Bacci”, 57127 Livorno, Italy 3. Department of Veterinary Medicine and Animal Science, University of Milan, 26900 Lodi, Italy 4. Department of Environment and Health, Italian National Institute of Health, 00161 Roma, Italy 5. Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy
Abstract
Fipronil (FIP) and imidacloprid (IMID) are two of the most commonly used ectoparasiticides to control parasites in pets. Compared with those of farm animals, their environmental risks have generally been considered low because of their limited use; however, the growing pet population and evolving treatment practices make this assumption challenging. To assess these risks, water samples were collected at an animal shelter in Italy to monitor the abundance of ectoparasiticides in aquatic environments. Additionally, laboratory-based ecotoxicological assays were carried out on a range of marine non-target species across different trophic levels (algae, copepods, and mussels). In vitro toxicity tests on human epithelial cell cultures were also implemented to examine potential cytotoxic effects at the levels of human exposure detectable in a domestic setting after pet treatment. Wastewater samples from the shelter contained 0.18 µg L−1 of IMID, 0.50 µg L−1 of FIP, and 0.20 µg L−1 of FIP-sulfone, with these concentrations remaining stable for 60 days. Chronic exposure to FIP and IMID at 30.0 µg L−1 impaired the mobility of the copepods. The EC10 and EC20 values were determined to be 1.7 (0.06–6.59) µg L−1 and 2.8 (0.436–8.51) µg L−1 for FIP and 2.6 (0.80–6.33) µg L−1 and 7.6 (3.12–15.8) µg L−1 for IMID, respectively. FIP and IMID exposure led to lipid peroxidation in the digestive glands and gills of mussels, whereas only IMID exposure increased acetylcholinesterase activity in the digestive glands at concentrations between 0.5 and 5.0 µg L−1. Additionally, both fipronil and imidacloprid triggered the production of reactive oxygen species and lipid peroxidation and decreased the viability of human keratinocyte cells in a concentration-dependent manner. These findings highlight the persistence and potential risks of FIP and IMID, stressing the need for stricter regulations and further research on chronic environmental exposure to safeguard ecosystems and public health.
Reference62 articles.
1. European Medicines Agency (EMA)/Committee for Medicinal Products for Veterinary Use (CVMP) (2025, April 02). Reflection Paper on the Environmental Risk Assessment of Ectoparasiticidal Veterinary Medicinal Products Used in Cats and Dogs. Available online: https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-environmental-risk-assessment-ectoparasiticidal-veterinary-medicinal-products-used-cats-and-dogs_en.pdf. 2. Grand View Research (2025, April 02). Animal Health Market Size, Share & Trends Analysis Report by Product (Biologics, Pharmaceuticals), by Animal Type (Companion, Production), by Distribution Channel, by End-Use, By Region, and Segment Forecasts, 2025–2030. Available online: https://www.grandviewresearch.com. 3. European Scientific Counsel Companion Animal Parasites (ESCCAP) (2022). Control of Ectoparasites in Dogs and Cats, ESCCAP Guideline 03, ESCCAP. [7th ed.]. Available online: https://www.esccap.org/link-document/63/. 4. Pfister, K., and Armstrong, R. (2016). Systemically and cutaneously distributed ectoparasiticides: A review of the efficacy against ticks and fleas on dogs. Parasites Vectors, 9. 5. Lavan, R., Armstrong, R., Normile, D., and Vaala, W. (2020). Adherence to veterinary recommendations for ectoparasiticides purchased by cat owners in the USA. Parasites Vectors, 13.
|
|